Physician profile
Robert Ruelaz
NPI 1881749026
$22,087.17
in general payments reported to CMS, 2019-2025
16 companies · $3,481 in 2025
The $3,481 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,172 · 2020: $2,327 · 2021: $2,406 · 2022: $1,337 · 2023: $2,351 · 2024: $1,014 · 2025: $3,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,603 · Travel and Lodging: $1,343 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,602.88 |
| Travel and Lodging | $1,342.79 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,482.40 | 2019-2025 | Ensite, Aveir, Gallant |
| Boston Scientific Corporation | $2,675.32 | 2021-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $2,602.59 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $534.07 | 2019-2020 | |
| Biotronik INC. | $269.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $135.21 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.95 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $58.86 | 2021-2025 | Carto 3 |
| Cardiva Medical, INC. | $43.26 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $39.04 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Terumo Bct, INC. | $36.79 | 2021 | |
| Cvrx, INC. | $25.99 | 2022 | |
| Amarin Pharma, INC. | $23.43 | 2020 | |
| Inspire Medical Systems, INC. | $21.23 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $17.27 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ruelaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.